在一名HHV8阳性、HIV阴性患者中，利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。 - Suppr

Suppr

超能文献

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.

作者信息

Law Alastair B, Ryan Gail, Lade Stephen, Prince H Miles

出版信息

Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.

DOI:10.1007/s12185-010-0497-9

PMID:20146033

Abstract

摘要

相似文献

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.

Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.

Actas Dermosifiliogr. 2006 Jul-Aug;97(6):385-90. doi: 10.1016/s0001-7310(06)73425-1.

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.

Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.

Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.

Clin Transl Oncol. 2006 Jul;8(7):540-1. doi: 10.1007/s12094-006-0056-2.

Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):127-128. doi: 10.1089/aid.2017.0117. Epub 2018 Jan 18.

Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.

Leuk Lymphoma. 2008 Nov;49(11):2224-6. doi: 10.1080/10428190802389835.

Rituximab therapy for HIV-associated Castleman disease.

Blood. 2003 Oct 15;102(8):2786-8. doi: 10.1182/blood-2003-03-0951. Epub 2003 Jul 3.

Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.

Clin Rheumatol. 2007 Jul;26(7):1148-50. doi: 10.1007/s10067-006-0272-8. Epub 2006 Jul 6.

Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis.

Clin Infect Dis. 2001 Apr 1;32(7):1100-2. doi: 10.1086/319603. Epub 2001 Mar 15.

How I treat HHV8/KSHV-related diseases in posttransplant patients.

Blood. 2012 Nov 15;120(20):4150-9. doi: 10.1182/blood-2012-04-421412. Epub 2012 Sep 11.

引用本文的文献

Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.

J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25.

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.

Cancer Sci. 2018 Jan;109(1):199-206. doi: 10.1111/cas.13439. Epub 2017 Dec 28.

Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Front Med. 2017 Jun;11(2):287-292. doi: 10.1007/s11684-017-0510-2. Epub 2017 Apr 3.

Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.

Clin Drug Investig. 2014 Feb;34(2):159-61. doi: 10.1007/s40261-013-0159-9.

Multicentric Castleman's disease: a challenging diagnosis.

Pathol Oncol Res. 2013 Jul;19(3):345-51. doi: 10.1007/s12253-013-9619-z. Epub 2013 Mar 21.

Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.

MAbs. 2012 Mar-Apr;4(2):233-42. doi: 10.4161/mabs.4.2.19262. Epub 2012 Mar 1.

An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.

Antiviral Res. 2011 Jun;90(3):143-50. doi: 10.1016/j.antiviral.2011.03.175. Epub 2011 Mar 31.

本文引用的文献

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.

Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.

HIV-associated multicentric Castleman disease.

Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. doi: 10.1097/coh.0b013e328319bca9.

Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.

Am J Surg Pathol. 2008 Jul;32(7):1006-12. doi: 10.1097/PAS.0b013e318160ed97.

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Ann Intern Med. 2007 Dec 18;147(12):836-9. doi: 10.7326/0003-4819-147-12-200712180-00003.

Castleman disease.

Curr Opin Hematol. 2007 Jul;14(4):354-9. doi: 10.1097/MOH.0b013e328186ffab.

Actas Dermosifiliogr. 2006 Jul-Aug;97(6):385-90. doi: 10.1016/s0001-7310(06)73425-1.

Progression of classic Kaposi's sarcoma with rituximab.

J Am Acad Dermatol. 2005 Jul;53(1):155-7. doi: 10.1016/j.jaad.2004.12.048.

Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.

BMC Blood Disord. 2003 Dec 11;3(1):3. doi: 10.1186/1471-2326-3-3.

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.

Int J Cancer. 2004 Jan 20;108(3):473-4. doi: 10.1002/ijc.11601.

Rituximab therapy for HIV-associated Castleman disease.

Blood. 2003 Oct 15;102(8):2786-8. doi: 10.1182/blood-2003-03-0951. Epub 2003 Jul 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验